ChemoCentryx, Inc. Appoints Joseph M. Feczko, M.D. to Company's Board of Directors
Published: Apr 30, 2012
MOUNTAIN VIEW, Calif., April 30, 2012 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. (Nasdaq:CCXI) announced today that the Company has appointed Joseph M. Feczko, M.D. to the Company's Board of Directors, effective immediately. Dr. Feczko served as Senior Vice President and Chief Medical Officer of Pfizer Inc. and member of the Executive Leadership Team with global responsibilities for all aspects of the company's medical, regulatory and safety activities. Dr. Feczko is board-certified in Internal Medicine and Infectious Diseases and continues to be active in the pharmaceutical industry, serving on several other notable company boards.